ResMed | RMD - Net Income


ResMed reported $383.43M in Net Income for its fiscal quarter ending in June of 2026.





Net Income Change Date
Ansell USD 88.8M 65.5M Dec/2025
Artivion USD 2.42M 4.07M Dec/2025
AtriCure USD 4.06M 4.89M Sep/2026
Baxter International USD 294M 168M Sep/2026
Cochlear AUD 161.5M 69.6M Dec/2025
Cooper Companies USD 432.8M 510.7M Jun/2026
CSL USD 401M 96.5M Dec/2025
Dexcom USD 249.1M 49.6M Jun/2026
Edwards Lifesciences USD 307.5M 65.6M Sep/2026
Fisher Paykel Healthcare NZD 255.5M 42.5M Jun/2026
Globus Medical USD 141.17M 10.4M Sep/2026
Haemonetics USD 46.3M 13.3M Sep/2026
Idexx Laboratories USD 317.14M 21.27M Sep/2026
Inogen USD -5.96M 373K Sep/2024
Insulet USD 141.1M 46.1M Sep/2026
Integra LifeSciences USD 14.85M 10.37M Sep/2026
Intuitive Surgical USD 522.8M 295.3M Sep/2026
Medtronic USD 1.47B 227M Jun/2026
Philips EUR 27M 357M Sep/2026
Ramsay Health Care AUD 152.7M 32.4M Dec/2025
ResMed USD 383.43M 15.3M Jun/2026
Sigma Healthcare AUD -6.72M 10.02M Dec/2024
Sonic Healthcare AUD 236.68M 82.29M Dec/2024
Steris USD 213.7M 13.6M Sep/2026
Teleflex USD 927.43M 827.73M Sep/2026
Thermo Fisher Scientific USD 1.72B 15M Sep/2026